Encapsulation of a Neutral Molecule into a Cationic Clay Material: Structural Insight and Cytotoxicity of Resveratrol/Layered Double Hydroxide/BSA Nanocomposites.

drug delivery layered double hydroxide resveratrol

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
21 Dec 2019
Historique:
received: 04 12 2019
revised: 16 12 2019
accepted: 19 12 2019
entrez: 28 12 2019
pubmed: 28 12 2019
medline: 28 12 2019
Statut: epublish

Résumé

Resveratrol (RES) is a stilbenoid polyphenol with interesting antitumor activity compromised by its poor solubility and bioavailability; thus, new approaches are necessary to improve its therapeutic effectiveness. In the present study, bovine serum albumin coated layered double hydroxide (LDH-BSA) was employed to encapsulate RES in order to overcome the above-mentioned usage limits. To evaluate the feasibility of neutral RES complexation with cationic LDH, we carried out molecular dynamics simulation in order to predict its structure and stability. In the supramolecular complex formed with LDH, RES disposes itself in the interlamellar region of LDH where it is stabilized by intermolecular interactions. The physico-chemical characteristics of the resulting nanocomplexes were studied by X-ray powder diffraction, transmission electron microscopy, and attenuated total reflection Fourier transform infrared spectroscopy. The encapsulation efficiency and drug release studies were also performed. The combined experimental and computational approach were highly effective in giving insight into the interaction mode of the neutral RES with the charged LDH. Finally, the nanohybrid's anticancer ability was evaluated in human lung cancer cell line (A549) resulting in higher activity with respect to bare RES. Overall, the results showed that the nanocomposites are suitable for biomedical applications as delivery agents of RES.

Identifiants

pubmed: 31877789
pii: nano10010033
doi: 10.3390/nano10010033
pmc: PMC7022748
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Mol Med Rep. 2015 Apr;11(4):2459-64
pubmed: 25515619
Magn Reson Chem. 2008 Jul;46(7):625-9
pubmed: 18324741
J Comput Chem. 2013 Dec 15;34(32):2757-70
pubmed: 24000174
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Drug Target. 2018 Mar;26(3):242-251
pubmed: 28795851
Int J Pharm. 2001 Jun 4;220(1-2):23-32
pubmed: 11376964
Antioxidants (Basel). 2019 Jul 25;8(8):
pubmed: 31349656
J Phys Chem B. 2006 Aug 31;110(34):16923-9
pubmed: 16927982
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Jan;69(1):178-82
pubmed: 17509931
Mater Sci Eng C Mater Biol Appl. 2016 Mar;60:195-203
pubmed: 26706522
Oncol Rep. 2017 Aug;38(2):611-624
pubmed: 28627697
J Colloid Interface Sci. 2018 Jul 1;521:242-251
pubmed: 29574343
J Phys Chem B. 2010 Mar 11;114(9):3348-54
pubmed: 20148537
J Control Release. 2012 Mar 10;158(2):182-93
pubmed: 21978644
Clin Cancer Res. 2010 Dec 15;16(24):5942-8
pubmed: 21045084
Spectrochim Acta A Mol Biomol Spectrosc. 2007 Nov;68(3):669-79
pubmed: 17416548
Food Funct. 2018 Jul 17;9(7):3788-3797
pubmed: 29922792
Pharmaceutics. 2019 Sep 02;11(9):
pubmed: 31480706
J Control Release. 2001 Jun 15;73(2-3):121-36
pubmed: 11516493
Front Chem. 2019 Apr 04;7:179
pubmed: 31019908
Water Res. 2013 Aug 1;47(12):4159-68
pubmed: 23582669
J Comput Chem. 2005 Dec;26(16):1668-88
pubmed: 16200636
J Phys Chem A. 2015 May 7;119(18):4224-36
pubmed: 25867793
Nanoscale. 2013 Oct 21;5(20):9924-33
pubmed: 23986296
Nat Rev Drug Discov. 2006 Jun;5(6):493-506
pubmed: 16732220
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Molecules. 2018 Feb 16;23(2):
pubmed: 29462955
Phys Chem Chem Phys. 2013 Aug 28;15(32):13418-33
pubmed: 23873340
Biochim Biophys Acta. 2015 Jun;1852(6):1178-85
pubmed: 25446990
Int J Nanomedicine. 2018 Feb 13;13:917-937
pubmed: 29491707
Chem Commun (Camb). 2015 Feb 21;51(15):3024-36
pubmed: 25562489
Cancer Res. 2007 Dec 15;67(24):12007-17
pubmed: 18089832
Science. 1997 Jan 10;275(5297):218-20
pubmed: 8985016
Int J Pharm. 2018 Dec 1;552(1-2):225-234
pubmed: 30291957

Auteurs

Cristina Minnelli (C)

Dipartimento di Scienze della Vita e dell'Ambiente (DISVA), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Emiliano Laudadio (E)

Dipartimento di Scienze della Vita e dell'Ambiente (DISVA), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Roberta Galeazzi (R)

Dipartimento di Scienze della Vita e dell'Ambiente (DISVA), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Gianni Barucca (G)

Dipartimento di Scienze e Ingegneria della Materia, dell'Ambiente e Urbanistica (SIMAU), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Valentina Notarstefano (V)

Dipartimento di Scienze della Vita e dell'Ambiente (DISVA), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Mattia Cantarini (M)

Dipartimento di Scienze della Vita e dell'Ambiente (DISVA), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Tatiana Armeni (T)

Dipartimento Scienze Cliniche Specialistiche ed Odontostomatologiche, Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Giovanna Mobbili (G)

Dipartimento di Scienze della Vita e dell'Ambiente (DISVA), Università Politecnica delle Marche, via Brecce Bianche, 60131 Ancona, Italy.

Classifications MeSH